Annovera FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved August 10, 2018)
Brand name: Annovera
Generic name: ethinyl estradiol and segesterone acetate
Dosage form: Vaginal System
Company: The Population Council
Treatment for: Birth Control
Add Drugs.com as a trusted source
Add Drugs.com as a trusted source on Google to see more of our health news and information in your Google Search results.
- Tap the button to open Google's source settings.
- Tick the box next to Drugs.com.
- You can change it anytime in your Google settings.
Requires a signed-in Google account.
Annovera (ethinyl estradiol and segesterone acetate) is an estrogen and progestin vaginal contraceptive system indicated to prevent pregnancy for up to a year.
Development timeline for Annovera
| Date | Article |
|---|---|
| Aug 10, 2018 | Approval FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.